Award

437180-33794

Funder: U.S. Public Health Service

Funded outputs count: 2

Funder award ID: 437180-33794

OpenAlex ID: G5186451

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.

1992 · R A Figlin, A Belldegrun, et al. · Journal of Clinical Oncology · 124

Intracranial Recurrence of Carcinoma after Complete Surgical Resection of Stage I, II, and III Non-Small-Cell Lung Cancer

1988 · Robert A. Figlin, Steven Piantadosi, et al. · New England Journal of Medicine · 126